New York's primary care waiver
Only 5% of spending goes to primary care
New York has received approval from the Centers for Medicare and Medicaid Services (CMS) for a Medicaid waiver.
While the Medicaid waiver is not an expansion of coverage-New York has already expanded-it is an agreement to use Medicaid funds for other uses outside of direct service. In this instance, the Medicaid waiver is $8 billion to restructure and transform New York’s health system using patient-centered primary care to improve health, lower costs and reduce disparities.
According to the Primary Care Development Corporation, a not-for-profit, 2.3 million people across the state lack sufficient access to primary care, and only about 5% of healthcare spending goes to primary care. The shortage of providers is one of the chief reasons New York has one of the highest rates of avoidable hospital use and cost in the country.
In 2011, Governor Andrew Cuomo established a Medicaid Redesign Team by executive order with the goal of bending the 13% cost-growth curve for Medicaid. A stakeholder group has recommended phasing out fee for service and replacing it with a delivery system focused on care management.
NEXT: See our map of Medicaid expansion -->
Utah was the most recent state to announce expansion, and New Hampshire is waiting in the wings.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
AI Benefits PBMs, Health Plans and Formulary Decision Making | AMCP Nexus 2024
October 21st 2024Health plans and PBMs are using AI to aggregate data, summarize information and enhance their formulary decision-making processes, according to Douglas S. Burgoyne, Pharm.D., MBA, FAMCP, adjunct associate professor at the University of Utah College of Pharmacy.
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024
Published: October 21st 2024 | Updated: October 21st 2024Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy complications in patients. But this could be an early worsening of disease unrelated to treatment.
Read More
